Regeneron begins late-stage trial testing COVID-19 antibody cocktailRegeneron has begun a late-stage clinical trial testing its double “antibody cocktail” as a preventive treatment for COVID-19. Share XRegeneron begins late-stage trial testing COVID-19 antibody cocktailhttps://pharmaphorum.com/news/regeneron-begins-late-stage-trial-testing-covid-19-antibody-cocktail/
J&J’s Ebola vaccine approved in EUThe European Commission has approved Johnson & Johnson’s Ebola vaccine, developed by its Janssen pharmaceuticals unit and Bavarian Share XJ&J’s Ebola vaccine approved in EUhttps://pharmaphorum.com/news/jjs-ebola-vaccine-approved-in-eu/
US government buys most of world’s supply of COVID-19 drug remdesivirThe US government has acquired most of the global supply of Gilead’s COVID-19 drug remdesivir until September as Share XUS government buys most of world’s supply of COVID-19 drug remdesivirhttps://pharmaphorum.com/news/us-government-buys-most-of-worlds-supply-of-covid-19-drug-remdesivir/
Bharat Biotech begins trial of COVID-19 vaccine in India as cases mountBharat Biotech is to begin trials of a coronavirus vaccine in India as the country faces a rapidly growing Share XBharat Biotech begins trial of COVID-19 vaccine in India as cases mounthttps://pharmaphorum.com/news/bharat-biotech-begins-trial-of-covid-19-vaccine-in-india-as-cases-mount/
Sanofi and Translate Bio expand mRNA vaccine agreementSanofi’s Pasteur vaccines unit and Translate Bio have expanded a collaboration to develop mRNA-based vaccines across all infectious Share XSanofi and Translate Bio expand mRNA vaccine agreementhttps://pharmaphorum.com/news/sanofi-and-translate-bio-expand-mrna-vaccine-agreement/
GSK begins COVID-19 vaccine trial with CloverGlaxoSmithKline has begun a COVID-19 clinical trial with China’s Clover Biopharmaceuticals, combining its booster with the biotech’s early-stage vaccine. GSK said Share XGSK begins COVID-19 vaccine trial with Cloverhttps://pharmaphorum.com/news/gsk-begins-covid-19-vaccine-trial-with-clover/
AZ reportedly mulls biggest-ever pharma merger with GileadAlmost exactly six years ago AstraZeneca managed to convince investors to reject a takeover bid from Pfizer – Share XAZ reportedly mulls biggest-ever pharma merger with Gileadhttps://pharmaphorum.com/news/az-reportedly-mulls-biggest-ever-pharma-merger-with-gilead/
Gilead begins UK trials of COVID-19 drug remdesivirGilead has begun testing its COVID-19 coronavirus antiviral remdesivir in the UK, announcing plans to trial the drug Share XGilead begins UK trials of COVID-19 drug remdesivirhttps://pharmaphorum.com/news/gilead-begins-uk-trials-of-covid-19-drug-remdesivir/
Celltrion to develop coronavirus antibody and fast testSouth Korea’s Celltrion has joined the many pharma companies fighting the COVID-19 coronavirus outbreak, saying it is working Share XCelltrion to develop coronavirus antibody and fast testhttps://pharmaphorum.com/news/celltrion-antibody-and-fast-test/
